Vanda Pharmaceuticals | VNDA - 股息收益率

金融业

USD

USD 488.95M

现金及等价物

USD 84.85M

USD 198.77M

USD 347.26M

USD 145.16M

USD 4.96M

股息收益率

0

USD -10.28M

USD -8.31M

203

EPS每股收益

USD -0.09

股本和储备

USD 327.19M

USD 50.6M

债务利息支出

-1.37B

USD 3.15M

USD 356.2M

USD -18.9M

USD -1.14B

USD -40.66M

普通股股本

USD 58K

16.79

USD -22.92M

USD 198.77M

销售和管理费用

USD 39.28M

USD 1.85M

贸易债权人

USD 39.09M

应收帐款人

USD 47.1M

	Dy	更改		日
Akebia Therapeutics	0		0	2025-03
Anika Therapeutics	0		0	2025-03
AstraZeneca	USD 1.18		0.56	2026-03
Bristol-Myers Squibb	4.12		3.9	2026-03
Eli Lilly	0.58		0.16	2025-12
Enanta Pharmaceuticals	0		0	2025-03
Esperion Therapeutics	0		0	2025-03
Heron Therapeutics	0		0	2025-03
J&J	2.16		0.34	2026-03
Lexicon Pharmaceuticals	0		0	2025-03
Merck	2.76		0.36	2026-03
Minerva Neurosciences	0		0	2025-03
Novartis	2.9		0.22	2025-12
Pfizer	6.36		0.55	2026-03
Puma Biotechnology	0		0	2025-03
Sangamo BioSciences	0		0	2025-03
Sanofi	4.98		0.24	2026-03
Takeda	1.65		2.43	2026-03
Vanda Pharmaceuticals	0		0	2025-03